DK3484502T3 - Blodplasmafraktioner til behandling mod aldersrelaterede kognitive forstyrrelser - Google Patents
Blodplasmafraktioner til behandling mod aldersrelaterede kognitive forstyrrelser Download PDFInfo
- Publication number
- DK3484502T3 DK3484502T3 DK17841780.4T DK17841780T DK3484502T3 DK 3484502 T3 DK3484502 T3 DK 3484502T3 DK 17841780 T DK17841780 T DK 17841780T DK 3484502 T3 DK3484502 T3 DK 3484502T3
- Authority
- DK
- Denmark
- Prior art keywords
- blood plasma
- cognitive disorders
- related cognitive
- treatment against
- plasma fractions
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title 1
- 210000002381 plasma Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376529P | 2016-08-18 | 2016-08-18 | |
| US201662412258P | 2016-10-24 | 2016-10-24 | |
| PCT/US2017/029953 WO2018034712A1 (en) | 2016-08-18 | 2017-04-27 | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3484502T3 true DK3484502T3 (da) | 2021-10-25 |
Family
ID=61196950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17841780.4T DK3484502T3 (da) | 2016-08-18 | 2017-04-27 | Blodplasmafraktioner til behandling mod aldersrelaterede kognitive forstyrrelser |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20190321449A1 (da) |
| EP (2) | EP3995140A1 (da) |
| JP (3) | JP7316931B2 (da) |
| KR (3) | KR20190032614A (da) |
| CN (2) | CN115957309A (da) |
| AU (4) | AU2017312722B2 (da) |
| BR (1) | BR112019003172A2 (da) |
| CA (1) | CA3033051A1 (da) |
| CL (1) | CL2019000304A1 (da) |
| CY (1) | CY1124695T1 (da) |
| DK (1) | DK3484502T3 (da) |
| ES (1) | ES2899147T3 (da) |
| HR (1) | HRP20211628T1 (da) |
| HU (1) | HUE056294T2 (da) |
| IL (2) | IL304946A (da) |
| LT (1) | LT3484502T (da) |
| MA (1) | MA45692B1 (da) |
| MD (1) | MD3484502T2 (da) |
| MX (2) | MX2019001718A (da) |
| NZ (1) | NZ750885A (da) |
| PL (1) | PL3484502T3 (da) |
| PT (1) | PT3484502T (da) |
| RS (1) | RS62558B1 (da) |
| SG (1) | SG11201901273TA (da) |
| SI (1) | SI3484502T1 (da) |
| UA (1) | UA126232C2 (da) |
| WO (1) | WO2018034712A1 (da) |
| ZA (1) | ZA202004834B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3615057T3 (da) * | 2017-04-26 | 2024-01-02 | Alkahest Inc | Doseringsskema til behandling af kognitive svækkelser med blodplasmaprodukter |
| SG11202010115RA (en) | 2018-05-15 | 2020-11-27 | Alkahest Inc | Treatment of aging-associated disease with modulators of leukotriene a4 hydrolase |
| CN110724176B (zh) * | 2018-07-16 | 2021-10-26 | 北京豪思生物科技有限公司 | 一种治疗阿尔茨海默症的血浆蛋白分离物及其制备方法和应用 |
| CN110787187B (zh) * | 2018-07-16 | 2022-05-13 | 北京豪思生物科技股份有限公司 | 一种增强记忆力和提高认知功能的血浆混合物及其制备方法和应用 |
| EP4374921A3 (en) * | 2018-07-20 | 2024-06-19 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| JP7504090B2 (ja) | 2018-10-26 | 2024-06-21 | アルカヘスト，インコーポレイテッド | 疼痛、創傷治癒及び術後回復の改善のための血漿及び血漿画分の使用 |
| CN110448686B (zh) * | 2019-09-19 | 2022-11-04 | 北京豪思生物科技股份有限公司 | 铜蓝蛋白联合运铁蛋白的应用 |
| WO2021062007A1 (en) * | 2019-09-25 | 2021-04-01 | Cytegen Corp. | Treatment of mitochondrial deficits and age-related diseases using blood products |
| US11439687B2 (en) | 2019-11-04 | 2022-09-13 | Alkahest, Inc. | Blood plasma fractions for use in muscle regeneration |
| US11484551B2 (en) | 2019-11-20 | 2022-11-01 | Alkahest, Inc. | Method of treating liver failure with plasma fraction IV-4 |
| CA3156906A1 (en) | 2019-11-20 | 2021-05-27 | Alkahest, Inc. | Blood plasma fractions for use in liver regeneration |
| EP4426284A1 (en) | 2021-11-01 | 2024-09-11 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
| WO2024102244A1 (en) * | 2022-11-11 | 2024-05-16 | Alkahest, Inc. | Blood plasma fractions for improvement of myelination |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3869431A (en) | 1973-03-12 | 1975-03-04 | Firestone Tire & Rubber Co | Polyamides and their production |
| US4624780A (en) | 1982-06-28 | 1986-11-25 | Alpha Therapeutic Corporation | Fractionation of blood plasma |
| DE3612137A1 (de) * | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
| US5138034A (en) * | 1989-07-12 | 1992-08-11 | The Green Cross Corporation | Method of fractionating plasma proteins |
| US5110907A (en) | 1989-08-01 | 1992-05-05 | Alpha Therapeutic Corporation | Factor viii complex purification using heparin affinity chromatography |
| US5288853A (en) | 1992-04-30 | 1994-02-22 | Alpha Therapeutic Corporation | Factor viii purification process |
| US5219995A (en) | 1992-07-14 | 1993-06-15 | Alpha Therapeutic Corporation | Plasma fraction purification |
| US5561115A (en) * | 1994-08-10 | 1996-10-01 | Bayer Corporation | Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
| US20050143310A1 (en) * | 2001-05-11 | 2005-06-30 | Masaki Hirashima | Novel remedies for neurodegenerative disease |
| AU2003303198A1 (en) * | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| US20040146565A1 (en) * | 2003-01-28 | 2004-07-29 | Lauridsen Group Incorporated | First lipoprotein fraction and therapeutic compositions of same |
| US20130121979A1 (en) * | 2003-12-29 | 2013-05-16 | Allan Mishra | Method of treating cancer using platelet compositions |
| ES2257225B1 (es) | 2006-02-17 | 2007-03-16 | Grifols, S.A | Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion. |
| ES2332846B1 (es) * | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| EP2271382B1 (en) | 2008-04-15 | 2013-03-13 | Grifols Therapeutics Inc. | Two-stage ultrafiltration/diafiltration |
| WO2009155069A1 (en) * | 2008-05-28 | 2009-12-23 | Allan Mishra | Compositions and methods for treating psychiatric and neurodegenerative disorders |
| AU2013203043B2 (en) * | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| PT2994160T (pt) * | 2013-05-06 | 2019-08-07 | Baxalta Inc | Tratamento de sub-populações com doença de alzheimer com imunoglobulina g combinada |
| AU2014364182B2 (en) * | 2013-12-09 | 2019-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| ES2524516B1 (es) | 2014-05-29 | 2015-03-31 | Grifols Worldwide Operations Limited | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
| EA039316B1 (ru) * | 2016-10-24 | 2022-01-12 | Алкахест, Инк. | Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением |
| US11040068B2 (en) * | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| DK3615057T3 (da) * | 2017-04-26 | 2024-01-02 | Alkahest Inc | Doseringsskema til behandling af kognitive svækkelser med blodplasmaprodukter |
-
2017
- 2017-04-27 PL PL17841780T patent/PL3484502T3/pl unknown
- 2017-04-27 MD MDE20190622T patent/MD3484502T2/ro unknown
- 2017-04-27 JP JP2019508828A patent/JP7316931B2/ja active Active
- 2017-04-27 BR BR112019003172A patent/BR112019003172A2/pt not_active Application Discontinuation
- 2017-04-27 AU AU2017312722A patent/AU2017312722B2/en active Active
- 2017-04-27 CA CA3033051A patent/CA3033051A1/en active Pending
- 2017-04-27 NZ NZ750885A patent/NZ750885A/en unknown
- 2017-04-27 KR KR1020197007543A patent/KR20190032614A/ko not_active IP Right Cessation
- 2017-04-27 MX MX2019001718A patent/MX2019001718A/es unknown
- 2017-04-27 HU HUE17841780A patent/HUE056294T2/hu unknown
- 2017-04-27 EP EP21192528.4A patent/EP3995140A1/en active Pending
- 2017-04-27 UA UAA201901438A patent/UA126232C2/uk unknown
- 2017-04-27 HR HRP20211628TT patent/HRP20211628T1/hr unknown
- 2017-04-27 SI SI201730964T patent/SI3484502T1/sl unknown
- 2017-04-27 PT PT178417804T patent/PT3484502T/pt unknown
- 2017-04-27 IL IL304946A patent/IL304946A/en unknown
- 2017-04-27 KR KR1020247007926A patent/KR20240036720A/ko active Search and Examination
- 2017-04-27 SG SG11201901273TA patent/SG11201901273TA/en unknown
- 2017-04-27 IL IL264660A patent/IL264660B2/en unknown
- 2017-04-27 MA MA45692A patent/MA45692B1/fr unknown
- 2017-04-27 CN CN202211658689.8A patent/CN115957309A/zh active Pending
- 2017-04-27 KR KR1020227025297A patent/KR20220107322A/ko not_active IP Right Cessation
- 2017-04-27 CN CN201780057412.0A patent/CN109963582B/zh active Active
- 2017-04-27 WO PCT/US2017/029953 patent/WO2018034712A1/en unknown
- 2017-04-27 ES ES17841780T patent/ES2899147T3/es active Active
- 2017-04-27 DK DK17841780.4T patent/DK3484502T3/da active
- 2017-04-27 LT LTEPPCT/US2017/029953T patent/LT3484502T/lt unknown
- 2017-04-27 RS RS20211337A patent/RS62558B1/sr unknown
- 2017-04-27 EP EP17841780.4A patent/EP3484502B1/en active Active
-
2019
- 2019-02-05 CL CL2019000304A patent/CL2019000304A1/es unknown
- 2019-02-11 MX MX2024008963A patent/MX2024008963A/es unknown
- 2019-06-28 US US16/456,717 patent/US20190321449A1/en not_active Abandoned
-
2020
- 2020-01-09 AU AU2020200181A patent/AU2020200181B2/en active Active
- 2020-07-16 ZA ZA2020/04834A patent/ZA202004834B/en unknown
-
2021
- 2021-09-28 AU AU2021240142A patent/AU2021240142B2/en active Active
- 2021-11-05 CY CY20211100958T patent/CY1124695T1/el unknown
- 2021-12-15 JP JP2021203571A patent/JP7447069B2/ja active Active
-
2022
- 2022-01-24 US US17/582,974 patent/US20220152161A1/en active Pending
-
2023
- 2023-08-17 JP JP2023133021A patent/JP2023156459A/ja active Pending
-
2024
- 2024-09-16 AU AU2024219765A patent/AU2024219765A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3484502T3 (da) | Blodplasmafraktioner til behandling mod aldersrelaterede kognitive forstyrrelser | |
| EP3388004A4 (en) | TREATMENT INSTRUMENT | |
| IL253945B (en) | kdm1a inhibitors to treat the disease | |
| IL275482A (en) | Asketamine for the treatment of depression | |
| IL258471A (en) | 11,13-modified saxitoxins for the treatment of pain | |
| DK3307262T3 (da) | Forbindelser til anvendelse ved behandling af neuromuskulære lidelser | |
| EP3263053A4 (en) | Medical treatment instrument | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| DK3265087T3 (da) | Fremgangsmåde til behandling med tradipitant | |
| DK3192524T3 (da) | Hgf præparat egnet til behandling af neurologiske lidelser | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
| EP3269316A4 (en) | Treatment instrument | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3209295T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| PL3448340T3 (pl) | Pomocniczy element aplikacyjny do opatrywania ran | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| EP3275495A4 (en) | Treatment instrument | |
| DK3096775T5 (da) | SOCS-mimetika til behandling af sygdomme | |
| KR20180084983A (ko) | 암의 치료를 위한 피리미도-피리미다지논의 용도 | |
| IL259381B (en) | Miravegron for the treatment of retinal diseases | |
| DK3395350T3 (da) | Lægemiddel til behandling af hjerneinfarkt |